The determination of serum and urinary endocan concentrations in patients with bladder cancer

LALOĞLU E., Aksoy H., AKSOY Y., ÖZKAYA F., Akcay F.

ANNALS OF CLINICAL BIOCHEMISTRY, cilt.53, sa.6, ss.647-653, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 53 Sayı: 6
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1177/0004563216629169
  • Dergi Adı: ANNALS OF CLINICAL BIOCHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.647-653
  • Anahtar Kelimeler: Bladder cancer, endocan, serum, urine, ENDOTHELIAL GROWTH-FACTOR, FOLLOW-UP, VEGF-A, MARKER, EXPRESSION, BIOMARKERS, DIAGNOSIS, SURVIVAL, ESM-1, MOLECULE-1
  • Atatürk Üniversitesi Adresli: Evet

Özet

Background Endocan (endothelial cell-specific molecule-1) is a proteoglycan and plays an important role in angiogenesis and inflammation. The aim of this study was to evaluate of serum and urinary concentrations of endothelial cell-specific molecule-1 in bladder cancer.